iRhythm Technologies (IRTC) to Release Quarterly Earnings on Thursday

iRhythm Technologies (NASDAQ:IRTC) will likely be posting its Q4 2025 results after the market closes on Thursday, February 19th. Analysts expect iRhythm Technologies to post earnings of $0.02 per share and revenue of $202.6060 million for the quarter. Investors are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Thursday, February 19, 2026 at 4:30 PM ET.

iRhythm Technologies Price Performance

iRhythm Technologies stock opened at $152.11 on Thursday. The company has a debt-to-equity ratio of 5.32, a quick ratio of 4.50 and a current ratio of 4.63. The company has a market capitalization of $4.90 billion, a price-to-earnings ratio of -94.48 and a beta of 1.06. The company’s 50 day simple moving average is $168.02 and its 200-day simple moving average is $171.34. iRhythm Technologies has a 1 year low of $92.52 and a 1 year high of $212.00.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the company. Citigroup boosted their price objective on iRhythm Technologies from $205.00 to $242.00 and gave the company a “buy” rating in a report on Friday, October 31st. Freedom Capital raised iRhythm Technologies to a “strong-buy” rating in a research report on Thursday, January 15th. JPMorgan Chase & Co. raised their price objective on shares of iRhythm Technologies from $190.00 to $240.00 and gave the company an “overweight” rating in a report on Friday, October 31st. Canaccord Genuity Group boosted their target price on iRhythm Technologies from $193.00 to $212.00 and gave the stock a “buy” rating in a research note on Friday, October 31st. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of iRhythm Technologies in a research note on Thursday, January 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, iRhythm Technologies has a consensus rating of “Moderate Buy” and an average target price of $219.23.

Insider Buying and Selling

In related news, insider Patrick Michael Murphy sold 2,478 shares of iRhythm Technologies stock in a transaction on Tuesday, December 2nd. The shares were sold at an average price of $184.83, for a total value of $458,008.74. Following the completion of the sale, the insider owned 53,281 shares in the company, valued at approximately $9,847,927.23. The trade was a 4.44% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Chad Patterson sold 280 shares of the firm’s stock in a transaction dated Tuesday, December 2nd. The stock was sold at an average price of $184.83, for a total transaction of $51,752.40. Following the completion of the transaction, the insider owned 43,387 shares in the company, valued at approximately $8,019,219.21. The trade was a 0.64% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 1.10% of the stock is currently owned by company insiders.

Institutional Trading of iRhythm Technologies

Several large investors have recently made changes to their positions in the company. US Bancorp DE lifted its position in shares of iRhythm Technologies by 7.8% during the third quarter. US Bancorp DE now owns 1,042 shares of the company’s stock valued at $179,000 after purchasing an additional 75 shares in the last quarter. State of Wyoming grew its stake in shares of iRhythm Technologies by 16.0% during the fourth quarter. State of Wyoming now owns 616 shares of the company’s stock valued at $109,000 after buying an additional 85 shares during the last quarter. Alliancebernstein L.P. increased its stake in shares of iRhythm Technologies by 0.3% in the third quarter. Alliancebernstein L.P. now owns 37,489 shares of the company’s stock worth $6,448,000 after buying an additional 95 shares during the period. California State Teachers Retirement System lifted its holdings in iRhythm Technologies by 0.3% in the 2nd quarter. California State Teachers Retirement System now owns 28,917 shares of the company’s stock worth $4,452,000 after buying an additional 99 shares during the period. Finally, Vident Advisory LLC raised its holdings in iRhythm Technologies by 6.1% in the 3rd quarter. Vident Advisory LLC now owns 2,442 shares of the company’s stock worth $420,000 after purchasing an additional 141 shares in the last quarter.

About iRhythm Technologies

iRhythm Technologies, Inc is a medical technology company that develops and commercializes wearable cardiac monitoring devices and associated data analytics services. Founded in 2006 and headquartered in San Francisco, California, the company’s flagship product is the Zio® patch, a discreet, single-use, continuous ECG recorder designed to monitor heart rhythms for up to 14 days. iRhythm’s digital diagnostics platform combines biosensor technology with proprietary algorithms to detect arrhythmias and streamline data interpretation for physicians.

The Zio service is prescribed by cardiologists and other healthcare providers to aid in the diagnosis of atrial fibrillation, bradycardia, tachycardia and other rhythm disorders.